209 related articles for article (PubMed ID: 6152379)
1. The effects of antiallergic and bronchodilator drugs on platelet-activating factor (PAF-acether) induced bronchospasm and platelet aggregation.
Lewis AJ; Dervinis A; Chang J
Agents Actions; 1984 Dec; 15(5-6):636-42. PubMed ID: 6152379
[TBL] [Abstract][Full Text] [Related]
2. LG 30435, a new bronchodilator/antiallergic agent, inhibits PAF-acether induced platelet aggregation and bronchoconstriction.
Criscuoli M; Subissi A; Daffonchio L; Omini C
Agents Actions; 1986 Nov; 19(3-4):246-50. PubMed ID: 3103400
[TBL] [Abstract][Full Text] [Related]
3. Dependency of the Paf-acether induced bronchospasm on the lipoxygenase pathway in the guinea-pig.
Bonnet J; Thibaudeau D; Bessin P
Prostaglandins; 1983 Sep; 26(3):457-66. PubMed ID: 6419289
[TBL] [Abstract][Full Text] [Related]
4. Azelastine, a new antiallergic/antiasthmatic agent, inhibits PAF-acether-induced platelet aggregation, paw edema and bronchoconstriction.
Achterrath-Tuckermann U; Weischer CH; Szelenyi I
Pharmacology; 1988; 36(4):265-71. PubMed ID: 3380879
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological profile of 48740 R.P., a PAF-acether antagonist.
Lefort J; Sedivy P; Desquand S; Randon J; Coëffier E; Maridonneau-Parini I; Floch A; Benveniste J; Vargaftig BB
Eur J Pharmacol; 1988 Jun; 150(3):257-68. PubMed ID: 2843382
[TBL] [Abstract][Full Text] [Related]
6. Histamine and leukotriene-independent guinea-pig anaphylactic shock unaccounted for by Paf-acether.
Detsouli A; Lefort J; Vargaftig BB
Br J Pharmacol; 1985 Apr; 84(4):801-10. PubMed ID: 4005486
[TBL] [Abstract][Full Text] [Related]
7. Comparative effects of drugs on leukotrienes-, PAF-acether- and histamine- induced contractions of guinea-pig lung parenchymal strips.
Touvay C; Vilain B; Etienne A; Clostre F; Braquet P
Pharmacol Res Commun; 1986 Aug; 18 Suppl():91-110. PubMed ID: 3022312
[TBL] [Abstract][Full Text] [Related]
8. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
[TBL] [Abstract][Full Text] [Related]
9. Inhibition by ticlopidine of Paf-acether-induced in vitro aggregation of rabbit and human platelets.
Lalau Keraly C; Delautier D; Delabassee D; Chignard M; Benveniste J
Thromb Res; 1984 Jun; 34(6):463-71. PubMed ID: 6740569
[TBL] [Abstract][Full Text] [Related]
10. The platelet-independent release of thromboxane A2 by Paf-acether from guinea-pig lungs involves mechanisms distinct from those for leukotriene.
Lefort J; Rotilio D; Vargaftig BB
Br J Pharmacol; 1984 Jul; 82(3):565-75. PubMed ID: 6430375
[TBL] [Abstract][Full Text] [Related]
11. Effects of PAF-acether and structural analogues on platelet activation and bronchoconstriction in guinea-pigs.
Coëffier E; Borrel MC; Lefort J; Chignard M; Broquet C; Heymans F; Godfroid JJ; Vargaftig BB
Eur J Pharmacol; 1986 Nov; 131(2-3):179-88. PubMed ID: 3816952
[TBL] [Abstract][Full Text] [Related]
12. Effects of serum albumin, indomethacin and histamine H1-antagonists on Paf-acether-induced inflammatory responses in the skin of experimental animals and man.
Archer CB; MacDonald DM; Morley J; Page CP; Paul W; Sanjar S
Br J Pharmacol; 1985 May; 85(1):109-13. PubMed ID: 2862936
[TBL] [Abstract][Full Text] [Related]
13. Specific inhibition of PAF-acether-induced platelet activation by BN 52021 and comparison with the PAF-acether inhibitors kadsurenone and CV 3988.
Nunez D; Chignard M; Korth R; Le Couedic JP; Norel X; Spinnewyn B; Braquet P; Benveniste J
Eur J Pharmacol; 1986 Apr; 123(2):197-205. PubMed ID: 3086108
[TBL] [Abstract][Full Text] [Related]
14. Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation.
Fouque F; Vargaftig BB
Br J Pharmacol; 1984 Nov; 83(3):625-33. PubMed ID: 6439269
[TBL] [Abstract][Full Text] [Related]
15. PAF-acether may not mediate the third pathway of platelet aggregation since self-desensitization reduces the effects of low thrombin but enhances those of convulxin.
Wal F; Joseph D; Touqui L; Vargaftig BB
Thromb Haemost; 1985 Feb; 53(1):99-104. PubMed ID: 3992525
[TBL] [Abstract][Full Text] [Related]
16. Antiallergic effect of epinastine (WAL 801 CL) on immediate hypersensitivity reactions: (II). Antagonistic effect of epinastine on chemical mediators, mainly antihistaminic and anti-PAF effects.
Kamei C; Mio M; Kitazumi K; Tsujimoto S; Yoshida T; Adachi Y; Tasaka K
Immunopharmacol Immunotoxicol; 1992; 14(1-2):207-18. PubMed ID: 1350791
[TBL] [Abstract][Full Text] [Related]
17. Synergistic actions of PAF-acether and sodium arachidonate in human platelet aggregation. 1. Studies in normal human platelet rich plasma.
Altman R; Scazziota A; Rouvier J; Cacchione R
Thromb Res; 1986 Jul; 43(1):103-11. PubMed ID: 3014677
[TBL] [Abstract][Full Text] [Related]
18. Sch 37370: a new drug combining antagonism of platelet-activating factor (PAF) with antagonism of histamine.
Billah MM; Chapman RW; Watnick AS; Egan RW; Siegel MI; Kreutner W
Agents Actions Suppl; 1991; 34():313-21. PubMed ID: 1793070
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human and rabbit platelet activation by Ketotifen.
Devillier P; Arnoux B; Lalau Keraly C; Landes A; Marsac J; Benveniste J
Fundam Clin Pharmacol; 1990; 4(1):1-9. PubMed ID: 2111270
[TBL] [Abstract][Full Text] [Related]
20. Antagonists of PAF-acether do not suppress thrombin-induced aggregation of ADP-deprived and aspirin-treated human platelets.
Adnot S; Joseph D; Vargaftig BB
Agents Actions; 1987 Jun; 21(1-2):195-202. PubMed ID: 3115070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
